It is best for small whole-genome sequencing, targeted gene sequencing, metagenomics, and CRISPR validation. The NextSeq 550 has been in use since 2018 and is great for mid-range projects such as ...

The Genomics Core offers a wide range of genomic and DNA/RNA services. We operate the Illumina NovaSeq X Plus, NextSeq 550, and MiSeq platforms for all Next Generation Sequencing and offer an ...

Trade war with China? Check. Cuts to scientific research? Check.

At a launch event on Feb. 20, Roche detailed plans to enter Illumina's sequencing stronghold with a new platform. Roche's platform is in testing now and scheduled to launch commercially in 2026.

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

RBC Capital reiterated an Outperform rating and $247 price target on Illumina (ILMN) after Roche (RHHBY) presented scientific details about its sequencing by extension technology, with initial ...

Illumina is raising the curtain on its upcoming ... The company said its spatial technology will run on its current NextSeq and NovaSeq hardware through a new multimodal software platform, with ...

The spatial solution surpasses industry standards for scale and accuracy, and is compatible with Illumina NextSeq and NovaSeq sequencers, thereby materially reducing the cost of running large ...

Users will go through a chemistry workflow to permeabilize, hybridize, and make a cDNA library that will be fully compatible with illumina sequencers—both NovaSeq and NextSeq. Users can also ...